Neomed Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -20.78%
- Profit Growth -132.22%
- Ebitda -131.85%
- Net Worth -1.87%
- Total Assets -14.09%
About Neomed Pharmaceutical
Neomed Pharmaceutical Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2013 and has a history of 11 years and seven months. Its registered office is in Patna, Bihar, India.
The Corporate was formerly known as Valuenoble Lifecare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashwani Kumar, Ravi Singh, and Rita Singh serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51900BR2013PTC020708
- Company No.
020708
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Neomed Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwani Kumar  | Director | 09-Jul-2013 | Current |
| Ravi Singh | Director | 09-Jul-2013 | Current |
| Rita Singh | Director | 28-May-2014 | Current |
Financial Performance of Neomed Pharmaceutical.
Neomed Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 20.78% decrease. The company also saw a substantial fall in profitability, with a 132.22% decrease in profit. The company's net worth dipped by a decrease of 1.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neomed Pharmaceutical?
In 2017, Neomed Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neomed Pharmaceutical?
Unlock and access historical data on people associated with Neomed Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neomed Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neomed Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.